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ABSTRACT 
 
Nardostachys jatamansi is classified as hypno-sedative in Ayurveda. It is used in 
treatment of insomnia, hysteria and depressive illness. The plant abounds in 
sesquiterpenes predominantly; jatamansone and nardostachone. The plant has 
demonstrated several pharmacological activities including hepatoprotective, cardio 
protective and hypolipidemic and antifungal. The significant effect is on the central 
nervous system, as diverse pharmacological actions, ranging from sedative to nootropic 
have been reported. Animal and clinical research with jatamansone, the active principle 
of the plant, has justified hypno-sedative claim of Ayurveda. The review summarizes, 
phytochemical and pharmacological investigations carried out on the plant.   
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INTRODUCTION 
 
Nardostachys jatamansi DC., is important plant of the family Valerianceae. It is 
commonly known as Indian spikenard and found in Himalayas. N. jatamansi is a 
perennial herb. Rhizomes occurs in short pieces, has dark grey color and typical smell. 
Leaves are sessile and ovate. Flowers are dark–pink in color.  
 
In Ayurveda, N. jatamansi is used for nervous headache, excitement, menopausal 
symptoms, flatulence, epilepsy and intestinal colic. In combination with cold water, the 
oil is considered to be effective against nausea, stomachache, flatulence, liver problems, 
jaundice and kidney complaints, insomnia and headache. Externally, the oil is added to a 
steaming bath to treat inflammation of the uterus. The oils are also used in eye 
compounds and as poison antidotes1. Oil is reported to be useful in the treatment of  atrial 
flutter. 
 
Phytochemistry 
 
The roots of the plant contain essential oil, rich in sesquiterpenes and coumarins1. 
Jatamansone or valeranone (Fig. 1) is the principal sesquiterpene2, 3. Other sesquiterpenes 
include nardostachone (Fig. 2), dihydrojatamansin, jatamansinol, jatamansic acid4, 
jatamansinone, jatamansinol, oroseolol, oroselone, seselin, valeranal, nardostachyin5, 
nardosinone, spirojatamol6, jatamol A and B7, calarenol 8, seychellene, seychelane, 
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coumarin: jatamansin or xanthogalin 9, 10. A new sesquiterpene acid, nardin and new 
pyranocoumarin: 2’, 2’-dimethyl-3’-methoxy-3’, 4’-dihydropyranocoumarin have been 
reported 1. Actinidine, an alkaloid has been reported (Fig 3). 
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PHARMACOLOGY 
Gastrointestinal system 
Hepatoprotective activity 
 
Pretreatment of rats with 800 mg/kg body wt of the 50% ethanolic extract of N. 
jatamansi demonstrated significant hepatoprotective activity against thioacetamide 
induced hepatotoxicity. Marked reduction in raised levels of serum transaminase and 
alkaline phosphatase was observed. Pretreatment of the animals with the extract further 
JPRHC 
Review Article 
	
 2009  Page 279 
 
resulted in an increase in survival in rats intoxicated with LD90 dose of the hepatotoxic 
drug 11. 
  
Cardiovascular system 
Cardio protective and hypolipidemic activity 
Rats administered doxorubicin (15 mg/kg (-1), i.p.) showed myocardial damage 
that was manifested by the elevation of serum marker enzymes (lactate dehydrogenase, 
creatine phosphokinase, aspartate aminotransaminase and alanine aminotransaminase). 
The animals showed significant changes in the antioxidant enzymes (superoxide 
dismutase, catalase, glutathione peroxidase and glutathione-S-transferase) and lipid 
peroxidation levels. Pretreatment with N. jatamansi extract significantly prevented these 
alterations and restored the enzyme activity and lipid peroxides to near normal levels. 
Restoration of cellular normality accredits the N. jatamansi with a cytoprotective role in 
doxorubicin-induced cardiac damage 12. 
 
In a study, ethanolic extract of N. jatamansi was studied in Wistar albino rats for 
cardio protective activity against doxorubicin induced myocardial injury. Doxorubicin is 
inhibitor of fatty oxidation in the heart and results in cardio toxicity. The rats treated with 
a single dose of doxorubicin (15 mg/kg) intraperitoneally showed an increase in serum 
and cardiac lipids (cholesterol, triglycerides, free fatty acids and phospholipids), along 
with a significant rise in serum low density lipoproteins, very low density lipoproteins 
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and drop in high density lipoproteins levels, resulting in alteration of serum and cardiac 
lipid metabolizing enzymes.  
 
Pretreatment with an extract of N.jatamansi (500 mg/kg) orally for seven days to 
doxorubicin induced rats showed a significant prevention in the lipid status with the 
activities of the lipid metabolizing enzymes. Histopathological observations were also in 
correlation with the biochemical parameters. These findings suggest that the protective 
and hypolipidemic effect of N. jatamansi against doxorubicin induced myocardial injury 
in rats could possibly be mediated through its anti lipid peroxidative properties 13. 
 
A 50% ethanolic extract of Curcuma longa (tuber) and N. jatamansi (whole plant) 
elevated the HDL-cholesterol/total cholesterol ratio in triton-induced hyperlipidemic rats. 
There also was a reduction in the ratio of total cholesterol/phospholipids 14. 
 
Nervous system 
 
Acetyl cholinesterase inhibitory activity of methanolic and successive water 
extracts of N.jatamansi (rhizome), were investigated for acetyl cholinesterase inhibitory 
activity in vitro. Results indicated that methanolic extracts to be more active than water 
extracts. The IC (50) values obtained for methanolic and successive water extracts of 
N.jatamansi was 47.21mug/ml. These results partly substantiate the traditional use of 
N.jatamansi for improvement of cognition 15. 
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Anticonvulsant activity 
 
Ethanol extract of the roots of N. jatamansi was studied for its anticonvulsant 
activity and neurotoxicity, alone and in combination with phenytoin in rats. The results 
demonstrated a significant increase in the seizure threshold by N. jatamansi root extract 
against maximal electroshock seizure model as indicated by a decrease in the 
extension/flexion ratio. However, the extract was ineffective against pentylenetetrazole-
induced seizures. N. jatamansi root extract also showed minimal neurotoxicity against 
rota rod test at doses that increased the seizure threshold. Further, pretreatment of rats 
with phenytoin at a dose of 12.5, 25, 50 and 75 mg/kg in combination with 50mg/kg of N. 
jatamansi root extract resulted in a significant increase in the protective index of 
phenytoin from 3.63 to 13.18. The dose response studies of phenytoin alone and in 
combination with N. jatamansi extract on the serum levels of phenytoin clearly 
demonstrated the synergistic action of both the drugs 16. 
 
Antidepressant activity 
 
A 15-day treatment with an alcoholic root extract of N. jatamansi caused an 
overall increase in the levels of central monoamines and inhibitory amino acids, 
including a change in the levels of serotonin, 5-hydroxyindole acetic acid, gamma-amino 
butyric acid, and taurine in rat brain 17.  
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Antiparkinson’s activity 
 
Rats were treated with 200, 400, and 600 mg/kg body weight of N. jatamansi 
roots for 3 weeks. On day 21, 2 µl of 6-OHDA (12 µg in 0.01% in ascorbic acid-saline) 
was infused into the right striatum, while the sham-operated group received 2 µl of 
vehicle. Three weeks after the 6-OHDA injection, the rats were tested for 
neurobehavioural activity and were sacrificed after 6 weeks for the estimation of lipid 
peroxidation, reduced glutathione content, the activities of glutathione-S-transferase, 
glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase, 
quantification of catecholamines, dopaminergic D2 receptor binding and tyrosine 
hydroxylase expression. The increase in drug-induced rotations and deficits in locomotor 
activity and muscular coordination due to 6-OHDA injections were significantly and 
dose-dependently restored by N. jatamansi.  
 
Lesioning was followed by an increased lipid peroxidation and significant 
depletion of reduced glutathione content in the substantia nigra, which was prevented 
with N. jatamansi pretreatment. The activities of glutathione-dependent enzymes, 
catalase and superoxide dismutase, in striatum which were reduced significantly by 
lesioning, were dose-dependently restored by N. jatamansi. A significant decrease in the 
level of dopamine and its metabolites and an increase in the number of dopaminergic D2 
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receptors in striatum were observed after 6-OHDA injection, and both were significantly 
recovered following N. jatamansi treatment. All of these results were exhibited by an 
increased density of tyrosine hydroxylase immunoreactive fibers in the ipsilateral 
striatum of the lesioned rats following treatment with N. jatamansi; 6-OHDA injection 
had induced almost a complete loss of TH-IR fibers. This study indicates that the extract 
of N. jatamansi might be helpful in attenuating Parkinsonism18.  
 
Neuroprotective activity 
 
Pretreatment with an alcoholic extract of N. jatamansi dosed at 250 mg/kg of for 
15 days protected rats against focal ischemia caused by middle cerebral artery occlusion. 
The protective effect may be associated with improving glutathione content, inhibiting 
lipid peroxidation, and activity on the Na+/K+ ATPase and catalase enzyme systems 19.   
 
Nootropic activity 
 
The elevated plus maze and the passive avoidance paradigm were employed to 
evaluate learning and memory parameters. Three doses (50, 100, and 200 mg/kg, p.o.) of 
an ethanolic extract of N. jatamansi were administered for 8 successive days to both 
young and aged mice. The 200 mg/kg dose of N. jatmansi ethanolic extract significantly 
improved learning and memory in young mice and also reversed the amnesia induced by 
diazepam (1 mg/kg, i.p.) and scopolamine (0.4 mg/kg, i.p.).  
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Furthermore, it also reversed aging-induced amnesia due to natural aging of mice. As 
scopolamine-induced amnesia was reversed, it is possible that the memory improvement 
may be because of facilitation of cholinergic transmission in the brain. Hence, N. 
jatamansi might prove to be a useful memory restorative agent in the treatment of 
dementia seen in elderly persons. The underlying mechanism of action can be attributed 
to its antioxidant property 20. 
 
Antimicrobial activity 
 
Antifungal 
 
N. jatamansi essential oil demonstrated fungistatic activity against Aspergillus 
flavus, Aspergillus niger and Fusarium oxysporum 21   
 
Jatamansone (valeranone) 
 
Animal studies done on jatamansone have reported antioestrogenic, 
antiarrhythmic, antihypertensive, anticonvulsant, sedative and tranquilizing activities 22, 
23, 24, 25, 26. In animal experiments, a limiting effect upon convulsant thresholds and a 
reduction of motor coordination ability traceable to the sequiterpene ketone, valeranone 
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contained in the drug have been demonstrated. Jatamansone is anticonvulsive in effect 
without exhibiting neuroleptic characteristics25. 
 
Some experiments, typical for tranquillizers jatamansone prolonged barbiturate 
hypnosis, impaired rota rod performance, potentiate the body-temperature lowering 
activity of reserpine. Jatamansone exhibited anticonvulsant activity against electric shock 
and gastro protective actions. In toxicological studies on rats and mice an oral LD50 of 
greater than 3160 mg/kg was found, which suggests the possibility of a therapeutically 
useful dose ratio 3. 
  
Preliminary clinical studies with jatamansone reported reduced incidence of 
aggressiveness, restlessness, stubbornness and insomnia. In a study conducted on 
hyperkinetic children, jatamasnone, D-amphetamine and chlorpromazine were compared 
for efficacy. Jatamasnone and amphetamine significantly improved behavior but 
amphetamine was better in reducing aggressiveness and restlessness. Children with 
mental retardation showed little response to any of the drugs. Jatamansone has fewer side 
effects than D-amphetamine and chlorpromazine 27.  
 
Jatamansin  
The coumarin; jatamansin is efficacious in internal treatment of varicose veins 28.  
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CONCLUSION 
  
N. jatamansi is important plant of Ayurvedic materia medica. The plant is major 
ingredient of Ayurvedic formulations for the treatment of central nervous disorders. 
Animal investigations and to some extent, clinical trials, have justified the claim of 
Ayurveda.  Keeping in mind the side–effect profile of conventional antipsychotic drugs, 
N. jatamansi seems to be potential candidate for large scale clinical trials.  
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